General Information of Drug (ID: DMA9FH0)

Drug Name
Ensitiximab
Indication
Disease Entry ICD 11 Status REF
Pancreatic cancer 2C10 Phase 2 [1]
Cross-matching ID
TTD ID
D0KL4T

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)